Exeltis USA, Inc. v. Lupin Ltd.

Publication Date: 2024-03-04

Practice Area: Intellectual Property

Industry: Pharmaceuticals

Court: U.S. District Court of Delaware

Judge: District Judge Andrews

Attorneys:

For plaintiff: Martina Tyreus Hufnal, Douglas E. McCann, Gregory R. Boofer, Fish & Richardson P.C., Wilmington, DE; Philip K. Chen, Fish & Richardson P.C., Boston, MA; Brian Coggio, Excylyn Hardin-Smith, Fish & Richardson P.C., New York, NY; Megan A. Chacon, Madelyn McCormick, Bernard Cryan, Fish & Richardson P.C., San Diego, CA, for plaintiffs.

For defendant: John C. Phillips, Jr., David A. Bilson, Phillips McLaughlin & Hall, P.A., Wilmington, DE; Michael Nutter, McGuireWoods LLP, Chicago, IL; Corinne S. Hockman, McGuireWoods LLP, Raleigh, NC; Daniel Withers, McGuireWoods LLP, Dallas, TX; Merritt Westcott, McGuireWoods LLP, Houston, TX; Dennis D. Gregory, McGuireWoods LLP, Austin, TX for defendants.

Case number: 22-434-RGA

Court rejected proposed claim construction for testing method where patent language had failed to establish lexicography or disavowal to require specific test conditions.